Cart
sales@molnova.com
Home - Products - Others - Other Targets - Theasaponin E1

Theasaponin E1

CAS No. 220114-28-3

Theasaponin E1( —— )

Catalog No. M32310 CAS No. 220114-28-3

Theasaponin E1 has antitumor, anti-inflammatory, QR-inducing activity and obesity prevention effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 551 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Theasaponin E1
  • Note
    Research use only, not for human use.
  • Brief Description
    Theasaponin E1 has antitumor, anti-inflammatory, QR-inducing activity and obesity prevention effects.
  • Description
    Theasaponin E1 has antitumor, anti-inflammatory, QR-inducing activity and obesity prevention effects. Theasaponin E1 inhibits gastric emptying in mice and accelerates gastrointestinal transit. Theasaponin E1 destroys the salt tolerance of yeasts. Theasaponin E1 show antisweet activity. Theasaponin E1 has neuroprotective effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    220114-28-3
  • Formula Weight
    1231.4
  • Molecular Formula
    C59H90O27
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Fitoterapia. 2013 Jan;84:321-325.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • CycLuc1

    CycLuc1 is a brain penetrant luciferase substrate.

  • BRD7389

    BRD7389 is an inhibitor of RSK family kinase with IC50s of 1.5 μM, 2.4 μM, and 1.2 μM for RSK1, RSK2, and RSK3, respectively.

  • [Phe1Ψ(CH2-NH)Gly2]N...

    Potent agonist of the nociceptin (ORL1) receptor, demonstrated both in vitro and in vivo. Selective, competitive antagonism at the nociceptin receptor has also been reported (pA2 = 7.02 and 6.75 in the guinea pig ileum and mouse vas deferens respectively).

Sign In Join Free